Motion · S2M-03281 · 14 Sep 2005
Scottish Medicines Consortium - Breast Cancer Drug, Arimidex, Approved Ahead of the Rest of the United Kingdom
The motion
That the Parliament congratulates the Scottish Medicines Consortium (SMC) for backing, ahead of the rest of the United Kingdom, the use in Scotland of the breast cancer drug, anastrazole (Arimidex) for first-line therapy in the adjuvant treatment of postmenopausal women with oestrogen receptor-positive early invasive breast cancer; notes that in trials this drug cut the risk of cancer returning in older woman to less than one in four, and further notes that the backing is ahead of the appraisal by the National Institute for Health and Clinical Excellence (NICE) who may not be appraising this drug until November 2006 due to funding cuts of £3.5 million.
Supporters (13)
- Shiona Baird 14 Sep 2005
- Ms Rosemary Byrne 14 Sep 2005
- Mrs Margaret Ewing 14 Sep 2005
- Alex Neil 14 Sep 2005
- Mike Pringle 14 Sep 2005
- Sandra White 14 Sep 2005
- Phil Gallie 15 Sep 2005
- Adam Ingram 15 Sep 2005
- Eleanor Scott 15 Sep 2005
- Tommy Sheridan 16 Sep 2005
- Jamie Stone 19 Sep 2005
- Robin Harper 26 Sep 2005
- John Scott 27 Sep 2005
Source: the Scottish Parliament motions and amendments record.